AVADIS TEVANIAN - 07 Feb 2023 Form 4 Insider Report for Dolby Laboratories, Inc. (DLB)

Role
Director
Signature
/s/ Daniel Rodriguez, as Attorney-in-Fact for Avadis Tevanian
Issuer symbol
DLB
Transactions as of
07 Feb 2023
Transactions value $
-$116,427
Form type
4
Filing time
09 Feb 2023, 20:41:37 UTC
Previous filing
09 Feb 2022
Next filing
08 Feb 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DLB Class A Common Stock Award $0 +3.3K $0.00 3.3K 07 Feb 2023 Direct F1, F2
transaction DLB Class A Common Stock Sale -$116K -1.39K -2.55% $83.64 53.3K 07 Feb 2023 By Avadis Tevanian Jr. and Nancy Tevanian Trust u/a/d May 29 1996
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Award represents a total of 3,296 restricted stock units granted under the terms of the Issuer's 2020 Stock Plan. Each unit represents a contingent right to receive one share of the Issuer's Class A Common Stock upon vesting, which will occur on the earlier of (i) the first anniversary of the date of grant or (ii) the date immediately preceding the date of Issuer's 2024 annual meeting of stockholders, provided that, in either case, the Reporting Person continues to serve as a member of the Issuer's board of directors on such date.
F2 Shares held following the reported transactions include 3,296 restricted stock units, which are subject to forfeiture until they vest.

Remarks:

The sale reported in this Form 4 was effected pursuant to a 10b5-1 trading plan.